| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -2.4e-06 | 1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -6e-05 | 1 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 6.6e-05 | 1 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.00027 | 1 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0002 | 1 |
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | -0.00021 | 1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00029 | 1 |
| mRNA | itraconazole | CTRPv2 | pan-cancer | AAC | 0.00035 | 1 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.00045 | 1 |